Niraparib tosylate monohydrate is a salt-hydrate form of the active pharmaceutical ingredient niraparib. It is a PARP inhibitor used as a pharmaceutical raw material in the manufacturing of anticancer medications.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1613220-15-7
Niraparib
active pharmaceutical ingredient
Ceftolozane and tazobactam
active pharmaceutical ingredient
5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine
active pharmaceutical ingredient
[2-(3-Hydroxyphenyl)cyclohex-1-enyl]-N,N-dimethylmethanamine Hydrochloride
active pharmaceutical ingredient
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
active pharmaceutical ingredient
4-methylbenzenesulfonic acid;2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide;hydrate
ACNPUCQQZDAPJH-FMOMHUKBSA-N
CC1=CC=C(C=C1)S(=O)(=O)O.C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N.O